… to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced its … “ProQR was founded with the goal of developing RNA therapies for patients with high unmet medical need, and … About Sepofarsen Sepofarsen (QR-110) is an investigational RNA therapy designed to restore vision in Leber congenital …
… in 2019 as we advanced our portfolio of investigational RNA therapies for patients that suffer from inherited retinal … transplant. About QR-504a We are developing QR-504a as an RNA therapy for the treatment of FECD3. We plan to advance …